Literature DB >> 24114807

Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene.

Hana Hartmannova1, Milos Kubanek, Marek Sramko, Lenka Piherova, Lenka Noskova, Katerina Hodanova, Viktor Stranecky, Anna Pristoupilova, Jana Sovova, Tomas Marek, Jana Maluskova, Petr Ridzon, Josef Kautzner, Helena Hulkova, Stanislav Kmoch.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy with severe left ventricular diastolic dysfunction has been associated with marked exercise intolerance and poor prognosis. However, molecular pathogenesis of this phenotype remains unexplained in a large proportion of cases. METHODS AND
RESULTS: We performed whole exome sequencing as an initial genetic test in a large Czech family with 3 males affected by nonobstructive hypertrophic cardiomyopathy with severe left ventricular diastolic dysfunction in end-stage disease. A novel frameshift mutation of four-and-a-half LIM domain 1 gene (FHL1) (c.599_600insT; p.F200fs32X) was detected in these individuals. The mutation does not affect transcription, splicing, and stability of FHL1 mRNA and results in production of truncated FHL1 protein, which is contrary to heart tissue homogenate not detectable in frozen tissue sections of myocardial biopsy of affected males. The identified mutation cosegregated also with abnormal ECG and with 1 case of apical hypertrophic cardiomyopathy in heterozygous females. Although skeletal muscle involvement is a common finding in FHL1-related diseases, we could exclude myopathy in all mutation carriers.
CONCLUSIONS: We identified a novel FHL1 mutation causing isolated hypertrophic cardiomyopathy with X-chromosomal inheritance.

Entities:  

Keywords:  cardiomyopathy, hypertrophic; exome; heart failure, diastolic

Mesh:

Substances:

Year:  2013        PMID: 24114807     DOI: 10.1161/CIRCGENETICS.113.000245

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  14 in total

Review 1.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 2.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

3.  Fhl1 W122S causes loss of protein function and late-onset mild myopathy.

Authors:  Valentina Emmanuele; Akatsuki Kubota; Beatriz Garcia-Diaz; Caterina Garone; Hasan O Akman; Daniel Sánchez-Gutiérrez; Luis M Escudero; Shingo Kariya; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

4.  FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.

Authors:  ZhenXian Hu; Ying Zhu; Xiao Liu; Wei Zhang; Jing Liu; Shiwen Wu; Jiangxi Xiao; Yun Yuan; Zhaoxia Wang
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

Review 5.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

6.  Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness.

Authors:  S Kmoch; J Majewski; V Ramamurthy; S Cao; S Fahiminiya; H Ren; I M MacDonald; I Lopez; V Sun; V Keser; A Khan; V Stránecký; H Hartmannová; A Přistoupilová; K Hodaňová; L Piherová; L Kuchař; A Baxová; R Chen; O G P Barsottini; A Pyle; H Griffin; M Splitt; J Sallum; J L Tolmie; J R Sampson; P Chinnery; E Banin; D Sharon; S Dutta; R Grebler; C Helfrich-Foerster; J L Pedroso; D Kretzschmar; M Cayouette; R K Koenekoop
Journal:  Nat Commun       Date:  2015-01-09       Impact factor: 14.919

7.  Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.

Authors:  Akatsuki Kubota; Martí Juanola-Falgarona; Valentina Emmanuele; Maria Jose Sanchez-Quintero; Shingo Kariya; Fusako Sera; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 5.121

Review 8.  The sarcomeric M-region: a molecular command center for diverse cellular processes.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

Review 9.  Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy.

Authors:  Catarina Roma-Rodrigues; Alexandra R Fernandes
Journal:  Appl Clin Genet       Date:  2014-10-03

10.  Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.

Authors:  John Garcia; Jackie Tahiliani; Nicole Marie Johnson; Sienna Aguilar; Daniel Beltran; Amy Daly; Emily Decker; Eden Haverfield; Blanca Herrera; Laura Murillo; Keith Nykamp; Scott Topper
Journal:  Front Cardiovasc Med       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.